Community prevalence of SARS-CoV-2 in England: Results from the ONS Coronavirus Infection Survey Pilot
暂无分享,去创建一个
Thomas House | Ian Diamond | Julie V Robotham | Paul J Birrell | John N Newton | Jeremy Farrar | I. Diamond | T. House | A. Walker | J. Newton | P. Birrell | J. Robotham | J. Farrar | Andrew Gelman | K. Pouwels | Koen B Pouwels | Ann Sarah Walker | Nikola Bowers | Ian Boreham | Heledd Thomas | James Lewis | Iain Bell | John I Bell | Pete Benton | I. Bell | J. Bell | A. Gelman | N. Bowers | I. Boreham | H. Thomas | P. Benton | James W Lewis | Heledd Thomas | Andrew Gelman | Ian Boreham
[1] J. Lessler,et al. Estimating the burden of SARS-CoV-2 in France , 2020, Science.
[2] P. McCullagh. Regression Models for Ordinal Data , 1980 .
[3] Kari Stefansson,et al. Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.
[4] Quentin J. Leclerc,et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK , 2020, BMC Medicine.
[5] J. Carlin,et al. Multilevel regression and poststratification as a modeling approach for estimating population quantities in large population health studies: A simulation study , 2019, Biometrical journal. Biometrische Zeitschrift.
[6] Paul-Christian Bürkner,et al. brms: An R Package for Bayesian Multilevel Models Using Stan , 2017 .
[7] T. Rea,et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington , 2020, The New England journal of medicine.
[8] P. Glasziou,et al. Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis , 2020, medRxiv.
[9] J. Gabry,et al. Bayesian Applied Regression Modeling via Stan , 2016 .
[10] N. P. H. Lan,et al. The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Peng Gong,et al. Global supply-chain effects of COVID-19 control measures , 2020, Nature Human Behaviour.
[12] R. Geskus,et al. The natural history and transmission potential of asymptomatic SARS-CoV-2 infection , 2020, medRxiv.
[13] S. Wood. Thin plate regression splines , 2003 .
[14] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[15] J. Klausner,et al. Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician Collected Nasopharyngeal Swabs for Covid-19 Detection , 2020, medRxiv.
[16] Marta Betoldi. In Labour , 2003 .
[17] F. Lewis,et al. A tutorial in estimating the prevalence of disease in humans and animals in the absence of a gold standard diagnostic , 2012, Emerging Themes in Epidemiology.
[18] P. Glasziou,et al. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. , 2020, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.
[19] S. Merler,et al. Probability of symptoms and critical disease after SARS-CoV-2 infection , 2020, 2006.08471.
[20] N. G. Davies,et al. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study , 2020, The Lancet Public Health.
[21] E. Lavezzo,et al. Suppression of COVID-19 outbreak in the municipality of Vo, Italy , 2020, medRxiv.